Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
6.93
-0.04 (-0.57%)
At close: Nov 20, 2024, 4:00 PM
6.72
-0.21 (-3.03%)
Pre-market: Nov 21, 2024, 4:23 AM EST
Silence Therapeutics Employees
Silence Therapeutics had 109 employees as of December 31, 2023. The number of employees decreased by 13 or -10.66% compared to the previous year.
Employees
109
Change (1Y)
-13
Growth (1Y)
-10.66%
Revenue / Employee
$199,754
Profits / Employee
-$723,788
Market Cap
324.31M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Cerus | 637 |
Lexicon Pharmaceuticals | 285 |
Alpha Teknova | 211 |
COMPASS Pathways | 186 |
Absci | 155 |
Nyxoah | 147 |
Sanara MedTech | 108 |
Semler Scientific | 92 |
SLN News
- 1 day ago - Silence Therapeutics' Zerlasiran Has Competitive Concerns: Analyst - Benzinga
- 2 days ago - Top 3 Health Care Stocks You'll Regret Missing In Q4 - Benzinga
- 2 days ago - Silence Therapeutics Presents Late-Breaking Phase 2 Zerlasiran Data at 2024 American Heart Association (AHA) Annual Meeting - Business Wire
- 7 days ago - Silence Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights - Business Wire
- 8 days ago - Silence Therapeutics to Participate in Fireside Chat at the Jefferies London Healthcare Conference - Business Wire
- 2 months ago - Silence Therapeutics' RNAi Pipeline: Zerlasiran's Game-Changer Potential Is A 'Buy' - Seeking Alpha
- 2 months ago - Silence: Additional siRNA Drug Data Leads To Next Stages Of Development - Seeking Alpha
- 3 months ago - Silence Therapeutics to Webcast Presentations at Upcoming September Investor Conferences - Business Wire